Safe Bulkers, Inc. Reports First Quarter 2025 Results and Declares Dividend on Common Stock

Safe Bulkers, Inc. Reports First Quarter 2025 Results and Declares Dividend on Common Stock GlobeNewswire May 19, 2025 MONACO, May 19, 2025 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today its unaudited financial results for the three-month periods ended March 31, 2025. The […]

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barre Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barre Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting GlobeNewswire May 19, 2025 First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barre Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care in Matched Patient Populations Poster Presentations

BigCommerce to Present at Baird Global Consumer, Technology & Services Conference

BigCommerce to Present at Baird Global Consumer, Technology & Services Conference GlobeNewswire May 19, 2025 AUSTIN, Texas, May 19, 2025 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands, retailers, manufacturers and distributors, today announced that Chief Financial Officer Daniel Lentz

Medicare Boosts Reimbursement for Oncocyte’s Flagship Technology

Medicare Boosts Reimbursement for Oncocyte's Flagship Technology GlobeNewswire May 19, 2025 New price of $2,753 for the GraftAssureCore(TM) assay increases total addressable market size and margin opportunity Brings pricing in line with existing competitive technology Expands market appeal for prospective FDA-cleared kitted product at transplant centers IRVINE, Calif., May 19, 2025 (GLOBE NEWSWIRE) — Oncocyte

No Credit Check Loans – Credit Clock is the Number 1 Pick for US Customers

Memphis, May 19, 2025 (GLOBE NEWSWIRE) — Do you have a hard time making both ends meet and require immediate cash? In most cases, having a poor credit score can make it tough to locate a lender that is willing to give you a no credit check loan. However, there's no need to worry–we have

No Credit Check Loans – Credit Clock is the Number 1 Pick for US Customers

No Credit Check Loans – Credit Clock is the Number 1 Pick for US Customers Credit Clock emerges as the top-rated platform for US borrowers seeking no credit check loans in 2025, offering flexible repayment terms, fast approvals, and transparent loan options for those with bad or no credit. GlobeNewswire May 19, 2025 Memphis, May

TPI Composites to Sponsor World KidWind Challenge Wind Tunnel at ACP CLEANPOWER 2025

(NasdaqGM:TPIC), SCOTTSDALE, Ariz., May 19, 2025 (GLOBE NEWSWIRE) — TPI Composites, Inc. (NASDAQ: TPIC), today announced its sponsorship of the wind tunnel competition at the World KidWind Challenge, to be held at the American Clean Power Association's (ACP) CLEANPOWER Conference in Phoenix, Arizona, May 18-21, 2025. The World KidWind Challenge is a hands-on design challenge

TPI Composites to Sponsor World KidWind Challenge Wind Tunnel at ACP CLEANPOWER 2025

TPI Composites to Sponsor World KidWind Challenge Wind Tunnel at ACP CLEANPOWER 2025 GlobeNewswire May 19, 2025 SCOTTSDALE, Ariz., May 19, 2025 (GLOBE NEWSWIRE) — TPI Composites, Inc. (NASDAQ: TPIC), today announced its sponsorship of the wind tunnel competition at the World KidWind Challenge, to be held at the American Clean Power Association's (ACP) CLEANPOWER

Collegium to Participate in Upcoming Investor Conferences

(NASDAQ:COLL), STOUGHTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Mizuho Neuro & Ophthalmology Summit 2025Panel Presentation: Wednesday, May 21, 2025, at 11:25 a.m. ET Jefferies Global Healthcare ConferencePresentation: Thursday, June 5, 2025, at 1:25 p.m. ET The presentation

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

(NASDAQ:DRTS),(NASDAQ:DRTSW), – Interim Jan-2025 results from three trials of Alpha DaRT(R) in treating pancreatic cancer shared at prestigious 2025 ASCO GI Symposium and R&D Update Day, showing >90% disease control rate, impressive overall survival in sub-group analyses, and positive safety profile – – 75% systemic objective response rate (ORR) and 37.5% complete response rate meaningfully

Scroll to Top